MIST
Price
$0.75
Change
-$0.05 (-6.25%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
40.02M
45 days until earnings call
PRAX
Price
$33.37
Change
-$3.74 (-10.08%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
672.85M
33 days until earnings call
Ad is loading...

MIST vs PRAX

Header iconMIST vs PRAX Comparison
Open Charts MIST vs PRAXBanner chart's image
Milestone Pharmaceuticals
Price$0.75
Change-$0.05 (-6.25%)
Volume$9.82K
Capitalization40.02M
Praxis Precision Medicines
Price$33.37
Change-$3.74 (-10.08%)
Volume$3.35K
Capitalization672.85M
MIST vs PRAX Comparison Chart
Loading...
MIST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MIST vs. PRAX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MIST is a Hold and PRAX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (MIST: $0.75 vs. PRAX: $33.37)
Brand notoriety: MIST and PRAX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MIST: 99% vs. PRAX: 62%
Market capitalization -- MIST: $40.02M vs. PRAX: $672.85M
MIST [@Biotechnology] is valued at $40.02M. PRAX’s [@Biotechnology] market capitalization is $672.85M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MIST’s FA Score shows that 0 FA rating(s) are green whilePRAX’s FA Score has 0 green FA rating(s).

  • MIST’s FA Score: 0 green, 5 red.
  • PRAX’s FA Score: 0 green, 5 red.
According to our system of comparison, PRAX is a better buy in the long-term than MIST.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MIST’s TA Score shows that 4 TA indicator(s) are bullish while PRAX’s TA Score has 4 bullish TA indicator(s).

  • MIST’s TA Score: 4 bullish, 5 bearish.
  • PRAX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PRAX is a better buy in the short-term than MIST.

Price Growth

MIST (@Biotechnology) experienced а -66.67% price change this week, while PRAX (@Biotechnology) price change was -14.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.91%. For the same industry, the average monthly price growth was -11.19%, and the average quarterly price growth was -14.86%.

Reported Earning Dates

MIST is expected to report earnings on May 19, 2025.

PRAX is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-8.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRAX($673M) has a higher market cap than MIST($40M). PRAX YTD gains are higher at: -56.640 vs. MIST (-68.220). MIST has higher annual earnings (EBITDA): -37.83M vs. PRAX (-199.81M). PRAX has more cash in the bank: 393M vs. MIST (69.7M). PRAX has less debt than MIST: PRAX (1.37M) vs MIST (54.8M). PRAX has higher revenues than MIST: PRAX (8.55M) vs MIST (0).
MISTPRAXMIST / PRAX
Capitalization40M673M6%
EBITDA-37.83M-199.81M19%
Gain YTD-68.220-56.640120%
P/E RatioN/AN/A-
Revenue08.55M-
Total Cash69.7M393M18%
Total Debt54.8M1.37M4,003%
FUNDAMENTALS RATINGS
MIST: Fundamental Ratings
MIST
OUTLOOK RATING
1..100
70
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
97
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MISTPRAX
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 8 days ago
83%
Bullish Trend 8 days ago
84%
Declines
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
MIST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HOWL0.910.04
+4.81%
Werewolf Therapeutics
BNS48.370.85
+1.79%
Bank of Nova Scotia
BNTC12.760.21
+1.67%
Benitec Biopharma
LTC35.400.08
+0.23%
LTC Properties
RMBS46.15-6.53
-12.40%
Rambus

MIST and

Correlation & Price change

A.I.dvisor tells us that MIST and AKBA have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MIST and AKBA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MIST
1D Price
Change %
MIST100%
-6.61%
AKBA - MIST
33%
Poorly correlated
-2.59%
GYRE - MIST
29%
Poorly correlated
-4.37%
PRAX - MIST
29%
Poorly correlated
-10.08%
OSRH - MIST
29%
Poorly correlated
+68.03%
ADAP - MIST
28%
Poorly correlated
+7.74%
More

PRAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRAX has been loosely correlated with CDXS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if PRAX jumps, then CDXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRAX
1D Price
Change %
PRAX100%
-10.08%
CDXS - PRAX
43%
Loosely correlated
-8.03%
DNLI - PRAX
39%
Loosely correlated
-6.91%
XENE - PRAX
38%
Loosely correlated
-2.48%
IOVA - PRAX
37%
Loosely correlated
-8.62%
VERU - PRAX
35%
Loosely correlated
-8.43%
More